市場調查報告書
商品編碼
1465100
栓塞預防設備市場:按設備類型、應用程式和最終用戶分類 - 2024-2030 年全球預測Embolic Protection Devices Market by Device Type (Distal Filters, Distal Occlusion Devices, Proximal Occlusion Devices), Application (Cardiovascular Procedures, Neurovascular Procedures), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年栓塞預防設備市場規模為17.2億美元,預計2024年將達18.6億美元,2030年將達到29.8億美元,複合年成長率為8.11%。
栓塞保護裝置 (EPD) 是各種血管手術過程中使用的重要工具,用於捕獲和清除可能鬆動並進入血液並導致身體其他部位(例如大腦)阻塞的碎片。由於全球心臟相關疾病的增加,對 EPD 的需求不斷增加。 EPD 的部署將會增加,因為老年人口和老年人患病的風險更高,需要使用 EPD 進行干預。政府努力提高人們對心臟健康的認知,這增加了對 EPD 的需求,因為更頻繁地診斷出血管疾病意味著需要更多的干涉措施。新興國家醫療保健設施和可近性的改善為 EPD 的採用提供了有利的框架。某些栓塞防護裝置的產品召回引發了人們對 EPD 安全性、可靠性和有效性的擔憂。此外,某些 EPD 並不適合所有導管尺寸或類型,且 EPD 部署的複雜性可能會增加手術併發症的風險。開發更簡單、更通用的 EPD 可以解決適用性和部署問題,並提高 EPD 的效用。有利的政府政策和對環保署的迅速監管核准刺激了市場成長。
主要市場統計 | |
---|---|
基準年[2023] | 17.2億美元 |
預測年份 [2024] | 18.6億美元 |
預測年份 [2030] | 29.8億美元 |
複合年成長率(%) | 8.11% |
設備類型彈性、有效性和微創性增加了遠端過濾器的採用
遠端過濾器是一種小型籃狀裝置,放置在血管內治療部位之外。其主要功能是捕獲和清除手術過程中可能釋放到血液中的碎片。這些過濾器的設計目的是讓血液流過,同時捕獲足夠大的顆粒,如果它們進入較小的血管,就會造成阻塞和損壞。手術完成後,小心地取出遠端過濾器和任何截留的碎片。遠端過濾器廣泛用於涉及頸動脈和其他血管的干涉措施,其中預防栓塞很重要。遠端阻塞設備的工作原理是暫時阻止治療區域遠端(或之外)的血流。這種預防策略可防止栓塞顆粒向下游移動。該裝置通常由氣球或其他裝置組成,可以在手術過程中充氣以閉塞血管。在血流恢復之前,透過抽吸(抽吸)清除產生的任何碎片。這些裝置在捕獲所有潛在碎片非常重要的情況下特別有用,並且與其他方法結合使用以確保在恢復正常血流之前徹底清洗血液通常組合使用。近端阻塞設備暫時阻止治療部位附近(或之前)的血流。這是透過將阻塞設備放置在比治療部位更靠近心臟的位置來實現的,以防止碎片脫落並流向大腦或其他重要器官。在許多情況下,氣球被充氣以閉塞血管。近端阻塞設備的主要優點是它們可以防止栓塞顆粒進入治療部位,從而提供預防性保護。
應用範例 管理大容量介入心臟病學和手術的栓塞預防設備的需求不斷成長
栓塞防護裝置主要用於心臟和動脈介入治療,例如經皮冠狀動脈介入治療 (PCI)、頸動脈置入術和經導管主動脈瓣置換術(TAVR)。在這些手術過程中,栓塞碎片脫落並在血流中移動的風險很大。栓塞碎片會阻塞通往心臟和大腦的血管,造成潛在的嚴重後果。因此,部署栓塞防護裝置來捕捉這些碎片並確保手術的安全性和有效性。使用栓塞保護裝置已成為標準治療的一部分,以盡量減少中風和其他併發症的風險。神經血管手術涉及治療大腦內或與大腦相連的血管。在這種情況下,栓塞保護裝置用於透過捕獲在顱內或顱外動脈置入術或血管成形術等手術過程中可能釋放的碎片來預防中風。儘管這些設備在神經血管手術中的使用越來越多,但由於腦血管的解剖結構微妙而複雜,它們提出了獨特的挑戰。重點是防止因血栓和碎片阻礙血液流向大腦而引起的栓塞性中風。
區域洞察
以美國和加拿大為中心的美洲地區憑藉強大的醫療設備,在栓塞預防器材市場中佔有重要地位。美國的患者和醫療保健專業人員正在強調品質和有效性的重要性,這正在影響他們對更先進、更可靠的設備的購買行為。該地區也以其強大的研發活動而聞名,許多專利來自新興國家。在歐盟 (EU) 國家,由於人口老化和心血管疾病預防意識的增強,對栓塞防護裝置的需求不斷增加。歐盟嚴格的法規環境確保只有符合高安全性和有效性標準的設備才能投放市場,且消費者的購買決策受到可靠且經過臨床檢驗的設備的影響。 Horizon Europe 計畫等舉措支持研究和創新,包括醫療設備領域的研究和創新,並可以促進新的栓塞防護技術的開發。由於政府對改善醫療基礎設施的大力支持以及對心血管疾病意識的穩定提高,亞太地區是栓塞防護設備成長最快的市場。這些國家的投資和專利主要用於開發具有成本效益和高效的設備,以滿足當地需求。
FPNV定位矩陣
FPNV 定位矩陣對於評估栓塞預防設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對栓塞預防設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.栓塞預防器材市場規模及預測是多少?
2.在栓塞預防設備市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.栓塞預防器材市場的技術趨勢和法規結構是什麼?
4.栓塞預防設備市場主要供應商的市場佔有率為何?
5. 進入栓塞預防器材市場的適當型態和策略手段是什麼?
[180 Pages Report] The Embolic Protection Devices Market size was estimated at USD 1.72 billion in 2023 and expected to reach USD 1.86 billion in 2024, at a CAGR 8.11% to reach USD 2.98 billion by 2030.
Embolic protection devices (EPDs) are critical tools used during various vascular procedures to capture and remove debris that might become loose and enter the bloodstream, potentially causing blockages elsewhere in the body, such as the brain. An increase in heart-related conditions globally drives the need for EPDs, as they are often used in procedures addressing these issues. Older populations and senior citizens are at a higher risk for diseases requiring interventions that use EPDs, thus increasing the deployment of EPDs. More frequent diagnosis of vascular conditions leads to a higher number of interventions, and government initiatives to raise awareness for heart health have led to a higher need for EPDs. Improved healthcare facilities and access in emerging economies provide a conducive framework for the adoption of EPDs. Incidences of product recall of certain embolic protection devices raise concerns about the safety, reliability, and efficacy of EPDs. Moreover, some EPDs may not be compatible with all catheter sizes or types, and the complexity of deploying EPDs can increase the risk of procedural complications. Developing simpler, more versatile EPDs can address compatibility and deployment issues, increasing their utility. Favorable government policies and quicker regulatory approvals for EPDs stimulate market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.72 billion |
Estimated Year [2024] | USD 1.86 billion |
Forecast Year [2030] | USD 2.98 billion |
CAGR (%) | 8.11% |
Device Type: Emerging adoption of distal filters owing to their flexibility, effectiveness, and minimally invasive nature
Distal filters are small, basket-like devices placed beyond the treatment site in the blood vessel. Their primary function is to capture and remove debris that may be released into the bloodstream during a procedure. These filters are designed to allow blood to flow through while trapping particles large enough to cause blockages or damage if they were to travel to smaller vessels. After the procedure is complete, the distal filter and captured debris are carefully retrieved. Distal filters are widely used in interventions involving the carotid arteries and other vessels where preventing embolism is critical. Distal occlusion devices work by temporarily blocking the blood flow distal to (or beyond) the treatment site. This prevention strategy stops embolic particles from traveling downstream. The device typically consists of a balloon or another mechanism that can be inflated to occlude the vessel during the procedure. Any debris generated is then removed by aspiration (suction) before the blood flow is restored. These devices are particularly useful in situations where capturing all potential debris is crucial, and they are often used in conjunction with other methods to ensure thorough cleaning of the blood before normal flow is resumed. Proximal occlusion devices temporarily halt blood flow proximal to (or before) the treatment area. This is achieved by placing the occlusion device closer to the heart than the site of the procedure, which prevents any debris from being dislodged and traveling toward the brain or other critical organs. They often involve a balloon mechanism that can be inflated to block the vessel. The main advantage of proximal occlusion devices is that they prevent embolic particles from even entering the area being treated, offering a proactive form of protection.
Application: Expanding need for embolic protection devices to manage the large volume of cardiovascular interventions and surgeries
In cardiovascular procedures, embolic protection devices are predominantly used during interventions involving the heart and arteries, such as percutaneous coronary interventions (PCI), carotid artery stenting, and transcatheter aortic valve replacement (TAVR). During these procedures, the risk of embolic debris dislodging and traveling through the bloodstream is significant. The debris could potentially block blood vessels leading to the heart or brain, resulting in severe consequences. Therefore, embolic protection devices are deployed to catch this debris, ensuring the safety and effectiveness of the procedure. Their use has become a standard part of practices aimed at minimizing the risk of stroke and other complications during these interventions. Neurovascular procedures involve treatments of the blood vessels within the brain or those leading to the brain. Embolic protection devices in this context are used to prevent strokes by capturing debris that might be released during procedures such as stenting or angioplasty of intracranial or extracranial arteries. While the use of these devices in neurovascular procedures is growing, they pose unique challenges due to the delicate and complex nature of the brain's vascular anatomy. The emphasis is on protecting against embolic strokes, which are caused by blood clots or debris blocking blood flow to the brain.
Regional Insights
The Americas region, particularly the United States and Canada, shows a prominent presence in the embolic protection devices market, driven by its robust healthcare infrastructure and favorable regulatory support for medical device authorization. Patients and healthcare professionals in the U.S. emphasize the importance of quality and efficacy, influencing purchasing behavior towards more advanced and reliable devices. The region is also known for significant research and development activities, with numerous patents related to embolic protection devices originating from these countries. European Union (EU) countries demonstrate a strong need for embolic protection devices owing to the presence of an aging population and increasing awareness of cardiovascular disease prevention. The EU's stringent regulatory environment ensures that only devices that meet high safety and effectiveness standards reach the market, affecting consumer purchasing decisions toward trusted and clinically validated devices. Initiatives such as the Horizon Europe program support research and innovation, including in the medical device sector, which could lead to the development of new embolic protection technologies. APAC region showcases a rapidly growing market for embolic protection devices, owing to robust government support for improving the healthcare infrastructure and steadily increasing awareness for cardiovascular conditions. Investments and patents in these countries are primarily focused on developing cost-effective and efficient devices to meet local needs.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Embolic Protection Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Embolic Protection Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Embolic Protection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Balton Sp. z o. o., Boston Scientific Corporation, Contego Medical, Inc., Cook Group Incorporated, Cordis, Edwards Lifesciences Corporation, Emboline, Inc., Filterlex Medical Ltd., Inari Medical, Inc., InspireMD Inc., Invamed, Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NIPRO CORPORATION, Penumbra, Inc., Protembis GmbH, Silk Road Medical, Inc., Stryker Corporation, Terumo Medical Corporation, Transverse Medical Inc., and W. L. Gore & Associates, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Embolic Protection Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Embolic Protection Devices Market?
3. What are the technology trends and regulatory frameworks in the Embolic Protection Devices Market?
4. What is the market share of the leading vendors in the Embolic Protection Devices Market?
5. Which modes and strategic moves are suitable for entering the Embolic Protection Devices Market?